81200 Aspa gene
Also known as: ASPA gene testing, Canavan disease screening
Molecular analysis of the ASPA gene to identify mutations associated with Canavan disease, a fatal leukodystrophy.
In Plain Language
brain disorder gene test; leukodystrophy genetic screening
Clinical Context
Ordered to diagnose Canavan disease in infants with developmental regression, hypotonia, and neuroimaging findings of white matter disease.
RVU Information
CPT 81200 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81200?
CPT 81200 (Aspa gene) is a Pathology & Lab code. Molecular analysis of the ASPA gene to identify mutations associated with Canavan disease, a fatal leukodystrophy.
Who uses CPT code 81200?
CPT 81200 is used by Genetics, Neurology, Pathology. Ordered to diagnose Canavan disease in infants with developmental regression, hypotonia, and neuroimaging findings of white matter disease.
When is CPT 81200 used?
Ordered to diagnose Canavan disease in infants with developmental regression, hypotonia, and neuroimaging findings of white matter disease.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.